688553Sichuan Huiyu Pharmaceutical688553 info
$1.41info-2.35%24h
Global rank10383
Market cap$596.45M
Change 7d-
YTD Performance-33.93%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Sichuan Huiyu Pharmaceutical (688553) Stock Overview

    Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor and injection drugs in China and internationally. The company offers injection drug products, such as pemetrexed disodium, methrotraxate, docetaxel, azacitidine, oxaliplatin, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, sodium valproate concentrated solution, epirubicin hydrochloride, fulvestrant, milrinone, fluorouracil, sodium thiosulfate, zoledronic acid, zoledronic acid concentrated solution, cisatracurium besylate, bortezomib, octreotide acetate, doxorubicin, and palonosetron hydrochloride. Sichuan Huiyu Pharmaceutical Co., Ltd. was incorportaed in 2010 and is headquartered in Neijiang, China.

    688553 Stock Information

    Symbol
    688553
    Address
    Building 3Neijiang, 641000China
    Founded
    -
    Trading hours
    9:30 AM - 3:00 PM CST
    Website
    https://www.huiyupharma.com
    Country
    🇨🇳 China
    Phone Number
    86 83 2880 8001

    Sichuan Huiyu Pharmaceutical (688553) Price Chart

    -
    Value:-

    Sichuan Huiyu Pharmaceutical Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.41
    N/A
    Market Cap
    $596.45M
    N/A
    Shares Outstanding
    423.60M
    N/A
    Employees
    1.67K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org